Authors' response to letter by Sbrana et al. "Evolocumab improve intima media thickness regression in He-FH subjects on lipoprotein apheresis"

Nutr Metab Cardiovasc Dis. 2021 Jan 4;31(1):361-362. doi: 10.1016/j.numecd.2020.08.026. Epub 2020 Oct 20.

Authors

Ilenia Calcaterra¹, Alessio Buonaiuto¹, Gabriella Iannuzzo¹, Matteo N D Di Minno²

Affiliations

¹ Department of Clinical Medicine and Surgery, Federico II University of Naples, Italy.
² Department of Translational Medical Sciences, Federico II University of Naples, Italy. Electronic address: dario.diminno@hotmail.it.

PMID: 33257188
DOI: 10.1016/j.numecd.2020.08.026

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Blood Component Removal*
Carotid Intima-Media Thickness
Humans
Hyperlipoproteinemia Type II*
Lipoproteins
Prospective Studies

Substances

Antibodies, Monoclonal, Humanized
Lipoproteins
evolocumab